Good Catch Monday's
Every Monday, the MedStar Quality and Safety Department recognizes someone who has made a "good catch" to help raise awareness and to continue our journey as a High Reliability Organization. This past Monday, MHRI was recognized for a catch during one of our research studies. Read below for this particular story and how we all work together to keep our patients safe.
Medical research is not always
easy-to say the least! Participants in clinical research are a critical part
of advancing knowledge and clinical care. One of the most important aspects
of successful research is in engaging and retaining study patients that fit
the requirements of each very specific study. MedStar Health Research
Institute (MHRI) is the research arm that conducts research throughout our
organization, and one that you will undoubtedly hear more about in the coming
weeks and months. In the Good Catch story that follows, you will see how a
successful research program is contingent upon safe, high quality care
delivered by care providers and research teams alike across our system. Not
only does the Allergist at MGUH go above and beyond to keep this particular
study on track, but the entire MedStar team is recognized by the patient as
having delivered good care.
Today's Good Catch is
from MedStar Health Research Institute
A study participant came in to
take part in a research study. It had been determined that he was qualified
to participate, however, one exclusion of this particular study was allergy
to any of the medications that could possibly be used in the study. This participant
had reported a reaction to Bactrim (a sulfa drug) about 20 years ago, which
could indicate risk of allergy to one of the medications of the study. The
participant was unclear if the reaction he had had was a true allergy to
sulfa drugs. He was very interested in participating in the study, but the
research team and patient needed a better understanding of his allergy risk
before proceeding. The research team offered to connect him to an allergist
to learn more about his allergy status.
Once the study sponsor and IRB
approved allergy testing, with specific testing using the possible study
medicine, the team was able to get the participant in to see MGUH Allergist,
Dr. Stefano Luccioli, on short notice. On behalf of the research team at the
MedStar Community Clinical Research Center, Amy Loveland, GRADE Program
Manager shared: "We were beyond impressed that Dr. Luccioli was able and
willing to work this participant into his schedule with one day's notice,
having had no previous interactions with us. His documentation of his
impressions and recommendations in the medical record were crystal clear,
reflecting exactly what we all needed to know on behalf of the patient. Dr.
Luccioli worked our participant in at the very last minute in order to accommodate
our research timelines. The participant remarked to us how friendly and
helpful everyone at Dr. Luccioli's office was, and how smoothly the whole
process went. With a system as large as MedStar, it is heartening to know
that we can call upon colleagues across the system and they will do whatever
they can on behalf of our research participants. The final bonus is
that the participant communicated to us his satisfaction with every MedStar
team member with whom he has had contact."
The research team is
happy to report that the participant successfully completed his
medication allergy testing. He was cleared to participate in the study and
his diagnosis of "sulfa allergy" was clarified in his medical
record to "Bactrim allergy". He was recently randomized into the
study and now has a better understanding of his own medical condition.
Thank you Dr. Luccioli, Amy and
the entire team at MHRI, for constantly working so hard to keep our patients
safe. |
Be proactive. Be reliable. Be a
hero.
|
Comments
Post a Comment